{
  "docId": "019de073-7e4e-7689-a01c-e0840dac2b61",
  "docSlug": "97e34d6c4db7d9454440fee3efd43545",
  "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides",
  "authorId": "axcella-health",
  "authorName": "Axcella Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 55,
  "pageCount": 62,
  "prevPage": 54,
  "nextPage": 56,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 30,
  "notes": "The table compares Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID groups.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/55",
  "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61",
  "deckJsonHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61.json",
  "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-55",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.07,
        "x": 0.9,
        "y": 0.08
      },
      "kind": "image",
      "text": "Pinnacle Clinical Research logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c8d415e-3ed1-4582-a163-80b54c8e2e61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "list",
      "text": "Most frequent TEAEs are gastrointestinal; All SAEs and the death unrelated to study product; No safety or tolerability signals of concern were observed; confirmed by an independent unblinded DMC review",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a5507c6-0434-4020-9c29-09237304896a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.05,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Safety based on what subject received on day 1 of dosing. DMC, independent data monitoring committee; SAE, serious adverse event; TEAEs, treatment emergent adverse events",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c5647de-e8df-464d-a6d0-dfc4d6173923",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.9,
        "x": 0.05,
        "y": 0.26
      },
      "kind": "table",
      "text": "Safety data table comparing Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID across various TEAE and SAE metrics.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "499ec523-aa0d-47f8-9597-ea403cc31037",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "title",
      "text": "SAFETY AND TOLERABILITY REMAINS FAVORABLE BASED ON THE BLINDED REVIEW",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6be5d070-7fe5-4116-8c61-cd56ead3c6e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "SAFETY INTERIM ANALYSIS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c2e8824-771b-42d5-8b78-0576e248776f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "168ea1e9-2f99-4bab-8368-3f74768c79fa",
      "evidence": "table/data: Safety data table comparing Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID across various TEAE and SAE metrics.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}